Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics

Three-dimensional printing (3DP) technology enables an important improvement in the design of new drug delivery systems, such as gastroretentive floating tablets. These systems show a better temporal and spatial control of the drug release and can be customized based on individual therapeutic needs....

Full description

Saved in:
Bibliographic Details
Main Authors: Gloria Mora-Castaño (Author), Mónica Millán-Jiménez (Author), Isidoro Caraballo (Author)
Format: Book
Published: MDPI AG, 2023-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f481b01634a04778bacea98bb5ee1402
042 |a dc 
100 1 0 |a Gloria Mora-Castaño  |e author 
700 1 0 |a Mónica Millán-Jiménez  |e author 
700 1 0 |a Isidoro Caraballo  |e author 
245 0 0 |a Hydrophilic High Drug-Loaded 3D Printed Gastroretentive System with Robust Release Kinetics 
260 |b MDPI AG,   |c 2023-03-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics15030842 
500 |a 1999-4923 
520 |a Three-dimensional printing (3DP) technology enables an important improvement in the design of new drug delivery systems, such as gastroretentive floating tablets. These systems show a better temporal and spatial control of the drug release and can be customized based on individual therapeutic needs. The aim of this work was to prepare 3DP gastroretentive floating tablets designed to provide a controlled release of the API. Metformin was used as a non-molten model drug and hydroxypropylmethyl cellulose with null or negligible toxicity was the main carrier. High drug loads were assayed. Another objective was to maintain the release kinetics as robust as possible when varying drug doses from one patient to another. Floating tablets using 10-50% <i>w</i>/<i>w</i> drug-loaded filaments were obtained by Fused Deposition Modelling (FDM) 3DP. The sealing layers of our design allowed successful buoyancy of the systems and sustained drug release for more than 8 h. Moreover, the effect of different variables on the drug release behaviour was studied. It should be highlighted that the robustness of the release kinetics was affected by varying the internal mesh size, and therefore the drug load. This could represent a step forward in the personalization of the treatments, a key advantage of 3DP technology in the pharmaceutical field. 
546 |a EN 
690 |a 3D printing 
690 |a gastroretentive floating tablets 
690 |a high drug-loaded filaments 
690 |a FDM 
690 |a Affinisol™ 15LV 
690 |a HPMC 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 15, Iss 3, p 842 (2023) 
787 0 |n https://www.mdpi.com/1999-4923/15/3/842 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/f481b01634a04778bacea98bb5ee1402  |z Connect to this object online.